Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia

Neurobiology of Disease

Volumn 43, Issue 3, 2011, Pages 576-587

  García, Joanna ^a   Carlsson, Thomas ^b   Döbrössy, Máté ^a   Nikkhah, Guido ^a   Winkler, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cell transplantation; L DOPA induced dyskinesia; Motor behavior; Parkinson's disease; Serotonin

Indexed keywords

LEVODOPA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DYSKINESIA; FEMALE; LOCOMOTION; NONHUMAN; PARKINSON DISEASE; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

ANIMALS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; CELL COUNT; COMBINED MODALITY THERAPY; DOPAMINE; DYSKINESIA, DRUG-INDUCED; FEMALE; FETAL TISSUE TRANSPLANTATION; LEVODOPA; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SEROTONIN; SYMPATHOLYTICS;

EID: 79960271748     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.05.004     Document Type: Article

References (47)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 1946, 94:239-247.
2. Arai R., Karasawa N., Geffard M., Nagatsu T., Nagatsu I. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic l-amino acid decarboxylase. Brain Res. 1994, 667:295-299.
3. Breysse N., Carlsson T., Winkler C., Björklund A., Kirik D. The functional impact of intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. J. Neurosci. 2007, 27:5849-5856.
4. Brundin P., Barbin G., Strecker R.E., Isacson O., Prochiantz A., Björklund A. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res. 1988, 467(2):233-243.
5. Brundin P., Barker R.A., Parmar M. Neural grafting in Parkinson's disease: problems and possibilities. Prog. Brain Res. 2010, 184:265-294.
6. Carlsson T., Winkler C., Lundblad M., Cenci M.A., Björklund A., Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol. Dis. 2006, 21:657-668.
7. Carlsson T., Carta M., Winkler C., Björklund A., Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J. Neurosci. 2007, 27:8011-8022.
8. Carlsson T., Carta M., Muñoz A., Mattsson B., Winkler C., Kirik D., et al. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain 2009, 132:319-335.
9. Carta M., Carlsson T., Kirik D., Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833.
10. Carta M., Carlsson T., Muñoz A., Kirik D., Björklund A. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease. Mov. Disord. 2010, 25(Suppl 1):S174-S179.
11. Cenci M.A., Lee C.S., Björklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 1998, 10:2694-2706.
12. Dunnett S.B., Björklund A., Schmidt R.H., Stenevi U., Iversen S.D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 1983, 522:29-37.
13. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
14. Hagell P., Cenci M.A. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res. Bull. 2005, 68(1-2):4-15.
15. Kirik D., Winkler C., Björklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J. Neurosci. 2001, 21(8):2889-2896.
16. Kuan W.L., Lin R., Tyers P., Barker R.A. The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. Neurobiol. Dis. 2007, 25(3):594-608.
17. Lane E.L., Winkler C., Brundin P., Cenci M.A. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol. Dis. 2006, 22:334-345.
18. Lane E.L., Soulet D., Vercammen L., Cenci M.A., Brundin P. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. Neurobiol. Dis. 2008, 32(2):220-228.
19. Lane E.L., Brundin P., Cenci M.A. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiol. Dis. 2009, 35(1):42-51.
20. Lane E.L., Björklund A., Dunnett S.B., Winkler C. Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia. Prog. Brain Res. 2010, 184:295-309.
21. Lee C.S., Cenci M.A., Schulzer M., Björklund A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 2000, 123:1365-1379.
22. Ma Y., Tang C., Chaly T., Greene P., Breeze R., Fahn S., et al. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J. Nucl. Med. 2010, 51(1):7-15.
23. Maeda T., Nagata K., Yoshida Y., Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered L-DOPA. Brain Res. 2005, 1046:230-233.
24. Mandel R.J., Brundin P., Björklund A. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur. J. Neurosci. 1990, 2(10):888-894.
25. Maries E., Kordower J.H., Chu Y., Collier T.J., Sortwell C.E., Olaru E., Shannon K., Steece-Collier K. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 2006, 21:165-180.
26. Mendez I., Viñuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14years. Nat. Med. 2008, 14:507-509.
27. Navailles S., De Deurwaerdère P. Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl.) 2011, 213(2-3):213-242.
28. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63(1):57-72.
29. Nikkhah G., Winkler C., Rödter A., Samii M. Microtransplantation of nigral dopamine neurons: a step-by-step recipe. Neuromethods: Cell and Tissue Transplantation in the CNS 2000, 207-231. The Human Press, Totowa. S.B. Dunnett, A.A. Boulton, G.B. Baker (Eds.).
30. Ng K.Y., Chase T.N., Colburn R.W., Kopin I.J. L-DOPA-induced release of cerebral monoamines. Science 1970, 170:76-77.
31. Ng K.Y., Colburn R.W., Kopin I.J. Effects of L-DOPA on efflux of cerebral monoamines from synaptosomes. Nature 1971, 230:331-332.
32. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
33. Olanow C.W., Kordower J.H., Lang A.E., Obeso J.A. Dopaminergic transplantation for Parkinson's disease: current status and future prospects. Ann. Neurol. 2009, 66(5):591-596.
34. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic, San Diego. 5 Ed.
35. Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128(Pt 12):2977-2986.
36. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2010, 2(38):38-46.
37. Rylander D., Parent M., O'Sullivan S.S., Dovero S., Lees A.J., Bezard E., et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann. Neurol. 2010, 68(5):619-628.
38. Schallert T., Tillerson J. Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimising behavioral assessment of outcome. Innovative Models of CNS Disease: From Molecule to Therapy 1999, 131-151. Humana, Clifton, NJ.
39. Soderstrom K.E., Meredith G., Freeman T.B., McGuire S.O., Collier T.J., Sortwell C.E., et al. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol. Dis. 2008, 32(2):229-242.
40. Steece-Collier K., Soderstrom K.E., Collier T.J., Sortwell C.E., Maries-Lad E. Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. J. Comp. Neurol. 2009, 515(1):15-30.
41. Tanaka H., Kannari K., Maeda T., Tomiyama M., Suda T., Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 1999, 10(3):631-634.
42. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970, 24(3):485-493.
43. Vinuela A., Hallett P.J., Reske-Nielsen C., Patterson M., Sotnikova T.D., Caron M.G., Gainetdinov R.R., Isacson O. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Brain 2008, 131:3361-3379.
44. Winkler C., Bentlage C., Nikkhah G., Samii M., Björklund A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp. Neurol. 1999, 155(2):165-186.
45. Winkler C., Kirik D., Björklund A., Cenci M.A. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 2002, 10:165-186.
46. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 2005, 28:86-92.
47. Winkler C., Georgievska B., Carlsson T., Lacar B., Kirik D. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats. Neuroscience 2006, 141:521-531.